Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults

Neurobiology of Aging

Volumn 36, Issue 9, 2015, Pages 2568-2576

  Sprecher, Kate E ^a,b   Bendlin, Barbara B ^b,c   Racine, Annie M ^a,b   Okonkwo, Ozioma C ^b,c   Christian, Bradley T ^b   Koscik, Rebecca L ^b   Sager, Mark A ^b   Asthana, Sanjay ^b,c   Johnson, Sterling C ^b,c   Benca, Ruth M ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Amyloid; Midlife; PET; Self report; Sleep

Indexed keywords

PITTSBURGH COMPOUND B; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; AMYLOID BETA PROTEIN; ANILINE DERIVATIVE; APOLIPOPROTEIN E; THIAZOLE DERIVATIVE;

ADULT; ALZHEIMER DISEASE; AMYLOIDOSIS; ANGULAR GYRUS; ARTICLE; CINGULATE GYRUS; COGNITION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE REGISTRY; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; MEDIAL ORBITOFRONTAL CORTEX; MEDICAL OUTCOMES STUDY SLEEP SCALE; MIDDLE AGED; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SLEEP DISORDER ASSESSMENT; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLEEP TIME; SOMNOLENCE; AGED; BRAIN CORTEX; COHORT ANALYSIS; DIAGNOSTIC IMAGING; DISEASE COURSE; GENETICS; MENTAL HEALTH; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; RADIOGRAPHY; SLEEP DISORDER; STATISTICS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; APOLIPOPROTEINS E; CEREBRAL CORTEX; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY; SELF REPORT; SLEEP WAKE DISORDERS; STATISTICS AS TOPIC; THIAZOLES;

EID: 84940467043     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.05.004     Document Type: Article

References (58)

1. Ancoli-Israel S., Palmer B.W., Cooke J.R., Corey-Bloom J., Fiorentino L., Natarajan L., Liu L., Ayalon L., He F., Loredo J.S. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J.Am. Geriatr. Soc. 2008, 56:2076-2081.
2. Benedict C., Byberg L., Cedernaes J., Hogenkamp P.S., Giedratis V., Kilander L., Lind L., Lannfelt L., Schiöth H.B. Self-reported sleep disturbance is associated with Alzheimer's disease risk in men. Alzheimers Dement. 2014, http://dx.doi.org/10.1016/j.jalz.2014.08.104.
3. Bero A.W., Bauer A.Q., Stewart F.R., White B.R., Cirrito J.R., Raichle M.E., Culver J.P., Holtzman D.M. Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brain. J.Neurosci. 2012, 32:4334-4340.
4. Bero A.W., Yan P., Roh J.H., Cirrito J.R., Stewart F.R., Raichle M.E., Lee J.-M., Holtzman D.M. Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat. Neurosci. 2011, 14:750-756.
5. Buysse D.J. Sleep health: can we define it? Does it matter?. Sleep 2014, 37:9-17.
6. Cirrito J.R., Yamada K.A., Finn M.B., Sloviter R.S., Bales K.R., May P.C., Schoepp D.D., Paul S.M., Mennerick S., Holtzman D.M. Synaptic activity regulates interstitial fluid amyloid-β levels invivo. Neuron 2005, 48:913-922.
7. Ekirch A. At Day's Close 2005, W.W. Norton & Company, New York.
8. Fisher S.P., Vyazovskiy V.V. Local sleep taking care of high-maintenance cortical circuits under sleep restriction. Sleep 2014, 37:1727-1730.
9. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
10. Frohnhofen H., Roffe C. Intermittent nocturnal hypoxemia in individuals with dementia: prevalence and relationship with functional status. J.Am. Geriatr. Soc. 2012, 60:1997-1999.
11. Gooneratne N.S., Vitiello M.V. Sleep in older adults: normative changes, sleep disorders, and treatment options. Clin. Geriatr. Med. 2014, 30:591-627.
12. Halász P., Terzano M., Parrino L., Bódizs R. The nature of arousal in sleep. J.Sleep Res. 2004, 13:1-23.
13. Hays R., Stewart A. Sleep measures. Measuring Functioning and Well-being: The Medical Outcomes Study Approach 1992, 235-259. Duke University Press, Durham, NC. A. Stewart, J. Ware (Eds.).
14. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T.G., Pankratz V.S., Donohue M.C., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
15. Johns M.W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992, 15:376-381.
16. Johns M.W. Anew method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
17. Johnson S.C., Christian B.T., Okonkwo O.C., Oh J.M., Harding S., Xu G., Hillmer A.T., Wooten D.W., Murali D., Barnhart T.E., Hall L.T., Racine A.M., Klunk W.E., Mathis C.A., Bendlin B.B., Gallagher C.L., Carlsson C.M., Rowley H.A., Hermann B.P., Dowling N.M., Asthana S., Sager M.A. Amyloid burden and neural function in people at risk for Alzheimer's Disease. Neurobiol. Aging 2014, 35:576-584.
18. Ju Y.-E.S., McLeland J.S., Toedebusch C.D., Xiong C., Fagan A.M., Duntley S.P., Morris J.C., Holtzman D.M. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013, 70:587-593.
19. Kang J.-E., Lim M.M., Bateman R.J., Lee J.J., Smyth L.P., Cirrito J.R., Fujiki N., Nishino S., Holtzman D.M. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007.
20. Kapur V., Strohl K.P., Redline S., Iber C., O'Connor G., Nieto J. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath. 2002, 6:49-54.
21. Kim H., Young T. Subjective daytime sleepiness: dimensions and correlates in the general population. Sleep 2005, 28:625-634.
22. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J.Cereb. Blood Flow Metab. 1996, 16:834-840.
23. McKhann G.M., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
24. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
25. Nikodemova M., Finn L., Mignot E., Salzieder N., Peppard P.E. Association of sleep disordered breathing and cognitive deficit in APOE ε4 carriers. Sleep 2013, 36:873-880.
26. Nir Y., Staba R.J., Andrillon T., Vyazovskiy V.V., Cirelli C., Fried I., Tononi G. Regional slow waves and spindles in human sleep. Neuron 2011, 70:153-169.
27. Onen F., Moreau T., Gooneratne N.S., Petit C., Falissard B., Onen S.H. Limits of the Epworth Sleepiness Scale in older adults. Sleep Breath. 2013, 17:343-350.
28. Ooms S., Overeem S., Besse K., Rikkert M.O., Verbeek M., Claassen J.A.H.R. Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol. 2014, 71:971-977.
29. Osorio R.S., Ayappa I., Mantua J., Gumb T., Varga A., Mooney A.M., Burschtin O.E., Taxin Z., During E., Spector N., Biagioni M., Pirraglia E., Lau H., Zetterberg H., Blennow K., Lu S.-E., Mosconi L., Glodzik L., Rapoport D.M., de Leon M.J. The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol. Aging 2014, 35:1318-1324.
30. Osorio R.S., Pirraglia E., Gumb T., Mantua J., Ayappa I., Williams S., Mosconi L., Glodzik L., de Leon M.J. Imaging and cerebrospinal fluid biomarkers in the search for Alzheimer's disease mechanisms. Neurodegener. Dis. 2013, 13:163-165.
31. Palop J.J., Mucke L. Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
32. Poe G.R., Walsh C.M., Bjorness T.E. Cognitive neuroscience of sleep. Prog. Brain Res. 2010, 185:1-19.
33. Radloff L.S. The CES-d scale a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
34. Reitan R., Wolfson D. The Halstead-reitan Neuropsychological Test Battery: Theory and Clinical Interpretation 1993, Neuropsychology Press, Tucson. 2.
35. Roh J.H., Huang Y., Bero A.W., Kasten T., Stewart F.R., Bateman R.J., Holtzman D.M. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology. Sci. Transl. Med. 2012, 4:150ra122.
36. Royston P., Altman D.G., Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat. Med. 2006, 25:127-141.
37. Rupp T.L., Wesensten N.J., Balkin T.J. Trait-like vulnerability to total and partial sleep loss. Sleep 2012, 35:1163-1172.
38. Sager M.A., Hermann B., La Rue A. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. J.Geriatr. Psychiatry Neurol. 2005, 18:245-249.
39. Schneider L.S., Mangialasche F., Andreasen N., Feldman H., Giacobini E., Jones R., Mantua V., Mecocci P., Pani L., Winblad B., Kivipelto M. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J.Intern. Med. 2014, 275:251-283.
40. Sheline Y.I., Raichle M.E., Snyder A.Z., Morris J.C., Head D., Wang S., Mintun M.A. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol. Psychiatry 2010, 67:584-587.
41. Shiota S., Takekawa H., Matsumoto S., Takeda K., Nurwidya F., Yoshioka Y., Takahashi F., Hattori N., Tabira T., Mochizuki H., Takahashi K. Chronic intermittent hypoxia/reoxygenation facilitate amyloid-β generation in mice. J.Alzheimers Dis. 2013, 37:325-333.
42. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:280-292.
43. Spira A.P., Gamaldo A.A., An Y., Wu M.N., Simonsick E.M., Bilgel M., Zhou Y., Wong D.F., Ferrucci L., Resnick S.M. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013, 70:1537-1543.
44. Spira A.P., Yager C., Brandt J., Smith G.S., Zhou Y., Mathur A., Kumar A., Brašić J.R., Wong D.F., Wu M.N. Objectively measured sleep and β-amyloid burden in older adults: a pilot study. SAGE Open Med. 2014, 2.
45. Spreen O., Strauss E. ACompendium of Neuropsychological Tests 1998, Oxford University Press, New York. second ed.
46. Spritzer K., Hays R. MOS Sleep Scale: A Manual for Use and Scoring, Version 1.0 2003, RAND, Los Angeles, CA.
47. Thal D.R., Capetillo-Zarate E., Del Tredici K., Braak H. The development of amyloid beta protein deposits in the aged brain. Sci. Aging Knowl. Environ. 2006, 2006:re1.
48. Tononi G., Cirelli C. Time to be SHY? Some comments on sleep and synaptic homeostasis. Neural Plast. 2012, 2012. Article ID: 415250, 12 pp.
49. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in spm using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
50. Van Dongen H.P.A., Baynard M.D., Maislin G., Dinges D.F. Systematic interindividual differences in neurobehavioral impairment from sleep loss: evidence of trait-like differential vulnerability. Sleep 2004, 27:423-433.
51. Viala-Danten M., Martin S., Guillemin I., Hays R.D. Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial. Health Qual. Life Outcomes 2008, 6:113.
52. Vyazovskiy V.V., Olcese U., Lazimy Y.M., Faraguna U., Esser S.K., Williams J.C., Cirelli C., Tononi G. Cortical firing and sleep homeostasis. Neuron 2009, 63:865-878.
53. Wang Y., Zhang G., Zhou H., Barakat A., Querfurth H. Opposite effects of low and high doses of Aβ42 on electrical network and neuronal excitability in the rat prefrontal cortex. PLoS One 2009, 4:e8366.
54. Wechsler D. Wechsler Adult Intelligence Scale 3 1997, The Psychological Corporation, San Antonio.
55. Worthman C.M., Melby M. Toward a comparative developmental ecology of human sleep. Adolescent Sleep Patterns: Biological, Social, and Psychological Influences 2002, 69-117. Cambridge University Press, Cambridge. M.A. Carskadon (Ed.).
56. Xie L., Kang H., Xu Q., Chen M.J., Liao Y., Thiyagarajan M., O'Donnell J., Christensen D.J., Nicholson C., Iliff J.J., Takano T., Deane R., Nedergaard M. Sleep drives metabolite clearance from the adult brain. Science 2013, 342:373-377.
57. Yaffe K., Laffan A.M., Harrison S.L., Redline S., Spira A.P., Ensrud K.E., Ancoli-Israel S., Stone K.L. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011, 306:613-619.
58. Yan P., Bero A.W., Cirrito J.R., Xiao Q., Hu X., Wang Y., Gonzales E., Holtzman D.M., Lee J.-M. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J.Neurosci. 2009, 29:10706-10714.